Zhiling Li

机构：Guiyang Medical University, Sun Yat-sen University, Taiyuan Normal University, State Grid Corporation of China (China), Shantou University, Inner Mongolia Electric Power (China), Shanghai Children's Medical Center, Affiliated Hospital of Guizhou Medical University, First Affiliated Hospital of Shantou University Medical College, Baogang Group (China), Guangdong Academy of Medical Sciences, Sun Yat-sen University Cancer Center, Guangdong Provincial People's Hospital, Taiyuan University of Science and Technology, Southern Medical University, Taiyuan University of Technology · ORCID：0000-0002-1467-0641

发表论文 102 篇 · 总被引 1320 次 · h-index 21

代表论文

• Human osteoarthritic articular cartilage stem cells suppress osteoclasts and improve subchondral bone remodeling in experimental knee osteoarthritis partially by releasing TNFAIP3 (2023 · Stem Cell Research & Therapy · 被引 17)
• Gut Dysbiosis Drives Inflammatory Bowel Disease Through the CCL4L2‐VSIR Axis in Glycogen Storage Disease (2024 · Advanced Science · 被引 12)
• Safflower CtFT genes orchestrating flowering time and flavonoid biosynthesis (2024 · BMC Plant Biology · 被引 8)
• TNFAIP3 Derived from Skeletal Stem Cells Alleviated Rat Osteoarthritis by Inhibiting the Necroptosis of Subchondral Osteoblasts (2023 · Stem Cells · 被引 7)
• Empagliflozin in children with glycogen storage disease-associated inflammatory bowel disease: a prospective, single-arm, open-label clinical trial (2024 · Scientific Reports · 被引 6)
• A novel model for predicting immunotherapy response and prognosis in NSCLC patients (2025 · Cancer Cell International · 被引 4)